These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 33386805)

  • 1. Altered Neuroanatomical Asymmetries of Subcortical Structures in Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease.
    Fu Z; Zhao M; Wang X; He Y; Tian Y; Yang Y; Han Y; Li S
    J Alzheimers Dis; 2021; 79(3):1121-1132. PubMed ID: 33386805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting progression from subjective cognitive decline to mild cognitive impairment or dementia based on brain atrophy patterns.
    Lerch O; Ferreira D; Stomrud E; van Westen D; Tideman P; Palmqvist S; Mattsson-Carlgren N; Hort J; Hansson O; Westman E
    Alzheimers Res Ther; 2024 Jul; 16(1):153. PubMed ID: 38970077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Alteration of Medial Temporal Lobe Subfield in the Amnestic Mild Cognitive Impairment Stage of Alzheimer's Disease.
    He P; Qu H; Cai M; Liu W; Gu X; Ma Q
    Neural Plast; 2022; 2022():8461235. PubMed ID: 35111220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter integrity disruption in the pre-dementia stages of Alzheimer's disease: from subjective memory impairment to amnestic mild cognitive impairment.
    Shao W; Li X; Zhang J; Yang C; Tao W; Zhang S; Zhang Z; Peng D
    Eur J Neurol; 2019 May; 26(5):800-807. PubMed ID: 30584694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical asymmetries in normal, mild cognitive impairment, and Alzheimer's disease.
    Kim JH; Lee JW; Kim GH; Roh JH; Kim MJ; Seo SW; Kim ST; Jeon S; Lee JM; Heilman KM; Na DL
    Neurobiol Aging; 2012 Sep; 33(9):1959-66. PubMed ID: 21907459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural neuroimaging changes associated with subjective cognitive decline from a clinical sample.
    Riverol M; Ríos-Rivera MM; Imaz-Aguayo L; Solis-Barquero SM; Arrondo C; Montoya-Murillo G; Villino-Rodríguez R; García-Eulate R; Domínguez P; Fernández-Seara MA
    Neuroimage Clin; 2024; 42():103615. PubMed ID: 38749146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subjective Spatial Navigation Complaints - A Frequent Symptom Reported by Patients with Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease.
    Cerman J; Andel R; Laczo J; Vyhnalek M; Nedelska Z; Mokrisova I; Sheardova K; Hort J
    Curr Alzheimer Res; 2018; 15(3):219-228. PubMed ID: 29165083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated Brain MRI Volumetry Differentiates Early Stages of Alzheimer's Disease From Normal Aging.
    Zhao W; Luo Y; Zhao L; Mok V; Su L; Yin C; Sun Y; Lu J; Shi L; Han Y
    J Geriatr Psychiatry Neurol; 2019 Nov; 32(6):354-364. PubMed ID: 31480984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortex-to-caudate volume ratio as a predictor of cognitive decline in Alzheimer's disease and mild cognitive impairment.
    Na S; Kim T; Song IU; Hong YJ; Kim SH
    J Neurol Sci; 2024 Jul; 462():123113. PubMed ID: 38941706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-brain analysis reveals increased neuroanatomical asymmetries in dementia for hippocampus and amygdala.
    Wachinger C; Salat DH; Weiner M; Reuter M;
    Brain; 2016 Dec; 139(Pt 12):3253-3266. PubMed ID: 27913407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
    Yi HA; Möller C; Dieleman N; Bouwman FH; Barkhof F; Scheltens P; van der Flier WM; Vrenken H
    J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):425-32. PubMed ID: 25904810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal changes in surface based brain morphometry measures in amnestic mild cognitive impairment and Alzheimer's Disease.
    Bachmann T; Schroeter ML; Chen K; Reiman EM; Weise CM;
    Neuroimage Clin; 2023; 38():103371. PubMed ID: 36924681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline.
    Eliassen CF; Reinvang I; Selnes P; Grambaite R; Fladby T; Hessen E
    Brain Behav; 2017 Sep; 7(9):e00776. PubMed ID: 28948074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volumetric and shape analysis of the thalamus and striatum in amnestic mild cognitive impairment.
    Leh SE; Kälin AM; Schroeder C; Park MT; Chakravarty MM; Freund P; Gietl AF; Riese F; Kollias S; Hock C; Michels L
    J Alzheimers Dis; 2016; 49(1):237-49. PubMed ID: 26444755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Odor identification deficit in mild cognitive impairment and Alzheimer's disease is associated with hippocampal and deep gray matter atrophy.
    Hagemeier J; Woodward MR; Rafique UA; Amrutkar CV; Bergsland N; Dwyer MG; Benedict R; Zivadinov R; Szigeti K
    Psychiatry Res Neuroimaging; 2016 Sep; 255():87-93. PubMed ID: 27567325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline shape diffeomorphometry patterns of subcortical and ventricular structures in predicting conversion of mild cognitive impairment to Alzheimer's disease.
    Tang X; Holland D; Dale AM; Younes L; Miller MI
    J Alzheimers Dis; 2015; 44(2):599-611. PubMed ID: 25318546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrovascular disease influences functional and structural network connectivity in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Vipin A; Loke YM; Liu S; Hilal S; Shim HY; Xu X; Tan BY; Venketasubramanian N; Chen CL; Zhou J
    Alzheimers Res Ther; 2018 Aug; 10(1):82. PubMed ID: 30121086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Earlier Biomarkers for Alzheimer's Disease: A Multimodal Neuroimaging Study of Individuals with Subjective Cognitive Decline.
    Parker AF; Smart CM; Scarapicchia V; Gawryluk JR;
    J Alzheimers Dis; 2020; 77(3):1067-1076. PubMed ID: 32804127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting biological heterogeneity patterns in ADNI amnestic mild cognitive impairment based on volumetric MRI.
    Ezzati A; Zammit AR; Habeck C; Hall CB; Lipton RB;
    Brain Imaging Behav; 2020 Oct; 14(5):1792-1804. PubMed ID: 31104279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimaging basis in the conversion of aMCI patients with APOE-ε4 to AD: study protocol of a prospective diagnostic trial.
    Chen GQ; Sheng C; Li YX; Yu Y; Wang XN; Sun Y; Li HY; Li XY; Xie YY; Han Y
    BMC Neurol; 2016 May; 16():64. PubMed ID: 27176479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.